v3.26.3
RESTRUCTURING (Tables)
 6 Months Ended
Sep. 26, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve by Type of Cost
The following table summarizes the activity for restructuring reserves related to the market and regional alignment initiative as well as certain previously completed programs for the six months ended September 26, 2026, substantially all of which relates to employee severance, other employee costs, inventory reserves and lease termination fees:
Market and Regional Alignment Initiative
Previously Completed Programs(1)
Total
Balance as of March 28, 2026
$568 $739 $1,307 
Costs incurred, net of reversals2,292 (221)2,071 
Payments(2,519)(479)(2,998)
Balance as of September 26, 2026
$341 $39 $380 
__________
(1)    Reflects the Company’s Operational Excellence Program and portfolio rationalization initiatives, each of which closed as of March 29, 2025.
Schedule of Restructuring and Related Costs
The following presents the net restructuring costs by line item within the Company’s accompanying unaudited condensed consolidated statements of income:
Three Months EndedSix Months Ended
September 26, 2026September 27, 2025September 26, 2026September 27, 2025
(Dollars in Thousands)
Cost of goods sold$(219)$(141)$564 $(526)
Research and development— 349 (8)1,034 
Selling, general and administrative expenses(8)(4)1,515 962 
Total$(227)$204 $2,071 $1,470 
The tables below present restructuring and restructuring related costs by reportable segment:
Three Months EndedSix Months Ended
September 26, 2026September 27, 2025September 26, 2026September 27, 2025
(Dollars in Thousands)
Restructuring costs
Apheresis$(197)$(415)$(184)$(867)
MedSurg(7)540 2,302 1,116 
Corporate(23)79 (47)1,221 
Total$(227)$204 $2,071 $1,470 
Restructuring related costs
Apheresis$— $— $— $9 
MedSurg— — — — 
Corporate11 54 (29)103 
Total$11 $54 $(29)$112 
Total restructuring and restructuring related costs$(216)$258 $2,042 $1,582